Characterizing all-cause excess mortality patterns during COVID-19 pandemic in Mexico. 2021

Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
Department of Population Health Sciences, School of Public Health, Georgia State University, Atlanta, GA, USA. sdahal2@student.gsu.edu.

BACKGROUND Low testing rates and delays in reporting hinder the estimation of the mortality burden associated with the COVID-19 pandemic. During a public health emergency, estimating all cause excess deaths above an expected level of death can provide a more reliable picture of the mortality burden. Here, we aim to estimate the absolute and relative mortality impact of COVID-19 pandemic in Mexico. METHODS We obtained weekly mortality time series due to all causes for Mexico, and by gender, and geographic region from 2015 to 2020. We also compiled surveillance data on COVID-19 cases and deaths to assess the timing and intensity of the pandemic and assembled weekly series of the proportion of tweets about 'death' from Mexico to assess the correlation between people's media interaction about 'death' and the rise in pandemic deaths. We estimated all-cause excess mortality rates and mortality rate ratio increase over baseline by fitting Serfling regression models and forecasted the total excess deaths for Mexico for the first 4 weeks of 2021 using the generalized logistic growth model. RESULTS We estimated the all-cause excess mortality rate associated with the COVID-19 pandemic in Mexico in 2020 at 26.10 per 10,000 population, which corresponds to 333,538 excess deaths. Males had about 2-fold higher excess mortality rate (33.99) compared to females (18.53). Mexico City reported the highest excess death rate (63.54) and RR (2.09) compared to rest of the country (excess rate = 23.25, RR = 1.62). While COVID-19 deaths accounted for only 38.64% of total excess deaths in Mexico, our forecast estimate that Mexico has accumulated a total of ~ 61,610 [95% PI: 60,003, 63,216] excess deaths in the first 4 weeks of 2021. Proportion of tweets was significantly correlated with the excess mortality (ρ = 0.508 [95% CI: 0.245, 0.701], p-value = 0.0004). CONCLUSIONS The COVID-19 pandemic has heavily affected Mexico. The lab-confirmed COVID-19 deaths accounted for only 38.64% of total all cause excess deaths (333,538) in Mexico in 2020. This reflects either the effect of low testing rates in Mexico, or the surge in number of deaths due to other causes during the pandemic. A model-based forecast indicates that an average of 61,610 excess deaths have occurred in January 2021.

UI MeSH Term Description Entries
D008297 Male Males
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D002947 Cities A large or important municipality of a country, usually a major metropolitan center. Municipalities,Towns
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D061108 Social Media Platforms that provide the ability and tools to create and publish information accessed via the INTERNET. Generally these platforms have three characteristics with content user generated, high degree of interaction between creator and viewer, and easily integrated with other sites. Folksonomy,Mobile Social Media,Mobile Social Networks,Social Media Messaging,Social Tagging,Social Medium,Twitter Messaging,Web 2.0,Folksonomies,Media Messaging, Social,Media, Social,Messaging, Social Media,Messaging, Twitter,Mobile Social Medias,Mobile Social Network,Social Media Messagings,Social Media, Mobile,Social Network, Mobile,Social Taggings,Tagging, Social,Web 2.0s

Related Publications

Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
October 2021, Journal of Korean medical science,
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
January 2021, Journal of epidemiology,
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
April 2023, Medical journal, Armed Forces India,
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
December 2022, IJID regions,
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
May 2023, BMJ global health,
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
July 2020, BMJ (Clinical research ed.),
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
February 2021, Health affairs (Project Hope),
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
November 2022, Scientific reports,
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
March 2021, Turkish thoracic journal,
Sushma Dahal, and Juan M Banda, and Ana I Bento, and Kenji Mizumoto, and Gerardo Chowell
September 2022, Journal of general internal medicine,
Copied contents to your clipboard!